These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 2240210

  • 1. Different responses of trabecular and cortical bone to 1,25(OH)2D3 infusion.
    Bikle DD, Halloran BP, McGalliard-Cone C, Morey-Holton E.
    Am J Physiol; 1990 Nov; 259(5 Pt 1):E715-22. PubMed ID: 2240210
    [Abstract] [Full Text] [Related]

  • 2. Chronic administration of 1,25-dihydroxyvitamin D3: increased bone but impaired mineralization.
    Wronski TJ, Halloran BP, Bikle DD, Globus RK, Morey-Holton ER.
    Endocrinology; 1986 Dec; 119(6):2580-5. PubMed ID: 3780540
    [Abstract] [Full Text] [Related]

  • 3. Skeletal resistance to 1,25-dihydroxyvitamin D3 in osteopetrotic rats.
    Safadi FF, Hermey DC, Popoff SN, Seifert MF.
    Endocrine; 1999 Dec; 11(3):309-19. PubMed ID: 10786828
    [Abstract] [Full Text] [Related]

  • 4. 1,25 dihydroxyvitamin D3 alone or in combination with parathyroid hormone does not increase bone mass in young rats.
    Gunness-Hey M, Gera I, Fonseca J, Raisz LG, Hock JM.
    Calcif Tissue Int; 1988 Nov; 43(5):284-8. PubMed ID: 3145794
    [Abstract] [Full Text] [Related]

  • 5. Continuous infusion of 1,25-dihydroxyvitamin D3 stimulates bone turnover in the normal young mouse.
    Marie PJ, Travers R.
    Calcif Tissue Int; 1983 Jul; 35(4-5):418-25. PubMed ID: 6688545
    [Abstract] [Full Text] [Related]

  • 6. 1,25 Dihydroxyvitamin D3 modifies cyclosporine-induced bone loss.
    Epstein S, Schlosberg M, Fallon M, Thomas S, Movsowitz C, Ismail F.
    Calcif Tissue Int; 1990 Sep; 47(3):152-7. PubMed ID: 2224590
    [Abstract] [Full Text] [Related]

  • 7. Increased clearance of 1,25(OH)2D3 and tissue-specific responsiveness to 1,25(OH)2D3 in diabetic rats.
    Verhaeghe J, Suiker AM, Van Bree R, Van Herck E, Jans I, Visser WJ, Thomasset M, Allewaert K, Bouillon R.
    Am J Physiol; 1993 Aug; 265(2 Pt 1):E215-23. PubMed ID: 8368291
    [Abstract] [Full Text] [Related]

  • 8. Responsiveness of the intestinal 1,25-dihydroxyvitamin D3 receptor to magnesium depletion in the rat.
    Lemay J, Gascon-Barré M.
    Endocrinology; 1992 May; 130(5):2767-77. PubMed ID: 1315257
    [Abstract] [Full Text] [Related]

  • 9. [Comparative study of the effect of 1,25 dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on calcium homeostasis and bone tissue state in rats during hypokinesia].
    Sergeev IN, Blazheevich NV, Kaplanskiĭ AS, Shvets VN, Belakovskiĭ MS.
    Vopr Med Khim; 1987 May; 33(1):100-7. PubMed ID: 3495067
    [Abstract] [Full Text] [Related]

  • 10. 1,25-dihydroxyvitamin D3 corrects bone loss but suppresses bone remodeling in ovariohysterectomized beagle dogs.
    Malluche HH, Faugere MC, Friedler RM, Fanti P.
    Endocrinology; 1988 May; 122(5):1998-2006. PubMed ID: 3359973
    [Abstract] [Full Text] [Related]

  • 11. Vitamin D deficiency in guinea pigs: exacerbation of bone phenotype during pregnancy and disturbed fetal mineralization, with recovery by 1,25(OH)2D3 infusion or dietary calcium-phosphate supplementation.
    Rummens K, van Bree R, Van Herck E, Zaman Z, Bouillon R, Van Assche FA, Verhaeghe J.
    Calcif Tissue Int; 2002 Oct; 71(4):364-75. PubMed ID: 12196905
    [Abstract] [Full Text] [Related]

  • 12. A direct effect of 24,25-(OH)2D3 and 1,25-(OH)2D3 on the modeling of fetal mice long bones in vitro.
    Schwartz Z, Soskolne WA, Atkin I, Goldstein M, Ornoy A.
    J Bone Miner Res; 1989 Apr; 4(2):157-63. PubMed ID: 2786320
    [Abstract] [Full Text] [Related]

  • 13. Effect of dietary calcium on the response of bone to 1,25 (OH)2D3.
    Boyce RW, Weisbrode SE.
    Lab Invest; 1983 Jun; 48(6):683-9. PubMed ID: 6687909
    [Abstract] [Full Text] [Related]

  • 14. The effect of vitamin D on bone in vivo.
    Tam CS, Heersche JN, Jones G, Murray TM, Rasmussen H.
    Endocrinology; 1986 Jun; 118(6):2217-24. PubMed ID: 3486118
    [Abstract] [Full Text] [Related]

  • 15. Chronic 1,25-dihydroxyvitamin D3 administration in the rat reduces the serum concentration of 25-hydroxyvitamin D by increasing metabolic clearance rate.
    Halloran BP, Bikle DD, Levens MJ, Castro ME, Globus RK, Holton E.
    J Clin Invest; 1986 Sep; 78(3):622-8. PubMed ID: 3489007
    [Abstract] [Full Text] [Related]

  • 16. Contrasting effects of 1,25-dihydroxyvitamin D3 on bone matrix and mineral appositional rates in the mouse.
    Marie PJ, Hott M, Garba MT.
    Metabolism; 1985 Aug; 34(8):777-83. PubMed ID: 3839559
    [Abstract] [Full Text] [Related]

  • 17. Effects of 1,25-dihydroxyvitamin D3 on bone resorption and natural immunity in osteopetrotic (ia) rats.
    Schneider GB, Relfson M, Langman CB.
    J Bone Miner Res; 1994 Apr; 9(4):585-91. PubMed ID: 8030447
    [Abstract] [Full Text] [Related]

  • 18. Stimulation of undermineralized matrix formation by 1,25 dihydroxyvitamin D3 in long bones of rats.
    Hock JM, Gunness-Hey M, Poser J, Olson H, Bell NH, Raisz LG.
    Calcif Tissue Int; 1986 Feb; 38(2):79-86. PubMed ID: 3082498
    [Abstract] [Full Text] [Related]

  • 19. [Metabolism of 25-hydroxyvitamin D3 and its regulation in rats during hypokinesis].
    Sergeev IN, Arkhapchev IuP, Linberg LF, Blazheevich NV, Ushakov AS.
    Biokhimiia; 1984 Apr; 49(4):590-8. PubMed ID: 6329324
    [Abstract] [Full Text] [Related]

  • 20. The influence of vitamin D metabolites on the calcification of cartilage matrix and the C-propeptide of type II collagen (chondrocalcin).
    Hinek A, Poole AR.
    J Bone Miner Res; 1988 Aug; 3(4):421-9. PubMed ID: 3265578
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.